Join to View Full Profile
200 UCLA Medical PlazaSuite B265Los Angeles, CA 90095
Phone+1 310-267-9099
Fax+1 310-267-9099
Dr. Valle is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Radiation Oncology, 2018 - 2022
Geisel School of Medicine at DartmouthClass of 2017
Certifications & Licensure
CA State Medical License 2018 - 2026
American Board of Radiology Radiation Oncology
Publications & Presentations
PubMed
- Validation and Derivation of MicroRNA-based Germline Signatures Predicting Radiation Toxicity in Prostate Cancer.Amar U Kishan, Kristen McGreevy, Luca Valle, Michael Steinberg, Beth Neilsen
Clinical Cancer Research. 2025-04-07 - Hypofractionated radiotherapy for prostate cancer (HYDRA): an individual patient data meta-analysis of randomised trials in the MARCAP consortium.Amar U Kishan, Yilun Sun, Alison C Tree, Emma Hall, David Dearnaley
The Lancet. Oncology. 2025-04-01 - Destroy or delay: hormonal therapy in oligometastatic prostate cancer.Amar U Kishan, Luca F Valle
The Lancet. Oncology. 2025-03-01
Press Mentions
MiraDx Announces New Study Published in Clinical Cancer Research Validating PROSTOX™ Ultra Diagnostic Test for Predicting Radiation-Induced Late Toxicity in Prostate CancerApril 7th, 2025- Study Confirms Safety and Efficacy of Higher-Dose-Per-Day Radiation for Early-Stage Prostate CancerMarch 18th, 2025
- Study of Oligorecurrent Prostate Cancer Finds Winning CombinationMarch 5th, 2025
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
